Jacobs Levy Equity Management
OPTN

Jacobs Levy Equity Management’s OptiNose OPTN Stock Holding History

Jacobs Levy Equity Management’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-29,564
Closed -$1.33M – 1049
2021
Q3 		$1.33M Sell
29,564
-38
-0.1% -$1.59K 0.01% 693
2021
Q2 		$1.38M Sell
29,602
-1,378
-4% -$70.4K 0.01% 675
2021
Q1 		$1.72M Buy
30,980
+29,873
+2,699% +$1.82M 0.01% 635
2020
Q4 		$69K Buy
+1,107
New +$67.8K ﹤0.01% 1000

Other funds holding OPTN

MPU
MVM Partners (UK) London, United Kingdom $149M AUM 6.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return

Jacobs Levy Equity Management's OPTN Position: Q4 2021 in Review

Jacobs Levy Equity Management sold out of OptiNose (OPTN) in Q4 2021, closing a stake of 29,564 shares — an estimated $1.33M sold.

Jacobs Levy Equity Management first reported a position in OPTN in Q4 2020 and held it in 4 quarters. The position peaked at $1.72M in Q1 2021. 44 funds tracked by Wall St. Rank hold OPTN as of Q4 2021.

  • Jacobs Levy Equity Management reported no remaining OptiNose position as of Q4 2021 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 29,564 OptiNose shares in Q4 2021, an estimated $1.33M.
  • Jacobs Levy Equity Management first reported a position in OptiNose in Q4 2020 and held it in 4 quarters.
  • Jacobs Levy Equity Management's OptiNose position peaked at $1.72M in Q1 2021.
  • 44 funds tracked by Wall St. Rank held OptiNose as of Q4 2021.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2021, filed 14 Feb 2022.